Differential expression of a prophage-encoded glycocin and its immunity protein suggests a mutualistic strategy of a phage and its host by Denham, Emma L et al.
  
 University of Groningen
Differential expression of a prophage-encoded glycocin and its immunity protein suggests a
mutualistic strategy of a phage and its host
Denham, Emma L; Piersma, Sjouke; Rinket, Marleen; Reilman, Ewoud; de Goffau, Marcus C;





IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
it. Please check the document version below.
Document Version
Publisher's PDF, also known as Version of record
Publication date:
2019
Link to publication in University of Groningen/UMCG research database
Citation for published version (APA):
Denham, E. L., Piersma, S., Rinket, M., Reilman, E., de Goffau, M. C., & van Dijl, J. M. (2019). Differential
expression of a prophage-encoded glycocin and its immunity protein suggests a mutualistic strategy of a
phage and its host. Scientific Reports, 9(1), 2845. [2845]. https://doi.org/10.1038/s41598-019-39169-3
Copyright
Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the
author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).
Take-down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the
number of authors shown on this cover page is limited to 10 maximum.
Download date: 13-11-2019
1Scientific RepoRts |          (2019) 9:2845  | https://doi.org/10.1038/s41598-019-39169-3
www.nature.com/scientificreports
Differential expression of a 
prophage-encoded glycocin and 
its immunity protein suggests a 
mutualistic strategy of a phage and 
its host
Emma L. Denham1,2, Sjouke Piersma1, Marleen Rinket1, Ewoud Reilman1, Marcus C. de Goffau1,3 & 
Jan Maarten van Dijl1
Sublancin 168 is a highly potent and stable antimicrobial peptide secreted by the Gram-positive 
bacterium Bacillus subtilis. Production of sublancin gives B. subtilis a major competitive growth 
advantage over a range of other bacteria thriving in the same ecological niches, the soil and plant 
rhizosphere. B. subtilis protects itself against sublancin by producing the cognate immunity protein 
SunI. Previous studies have shown that both the sunA gene for sublancin and the sunI immunity gene 
are encoded by the prophage SPβ. The sunA gene is under control of several transcriptional regulators. 
Here we describe the mechanisms by which sunA is heterogeneously expressed within a population, 
while the sunI gene encoding the immunity protein is homogeneously expressed. The key determinants 
in heterogeneous sunA expression are the transcriptional regulators Spo0A, AbrB and Rok. 
Interestingly, these regulators have only a minor influence on sunI expression and they have no effect 
on the homogeneous expression of sunI within a population of growing cells. Altogether, our findings 
imply that the homogeneous expression of sunI allows even cells that are not producing sublancin 
to protect themselves at all times from the active sublancin produced at high levels by their isogenic 
neighbors. This suggests a mutualistic evolutionary strategy entertained by the SPβ prophage and its 
Bacillus host, ensuring both stable prophage maintenance and a maximal competitive advantage for 
the host at minimal costs.
The fitness of bacterial cells and populations belonging to a particular species is critically dependent on their 
ability to compete with other organisms. A highly successful competitor is the Gram-positive bacterium Bacillus 
subtilis, which thrives in the soil and plant rhizosphere. As shown through recent systems biological analyses, 
B. subtilis has an intricate regulatory architecture that allows it to rapidly and effectively adapt to changing con-
ditions1,2. This organism has also mastered the art of adapting to a wide range of environmental stresses and 
insults3,4 and, on top of that, B. subtilis secretes a cocktail of antimicrobial compounds into its environment that 
is deadly for a wide range of other microbes5,6. These traits ensure that B. subtilis can optimally benefit from any 
nutrients that become available in its environment1,2.
A very potent and stable antimicrobial agent produced by B. subtilis is sublancin 168 (in short sublancin). 
Studies have shown that sublancin is a 37-residue peptide composed of two helices, which are connected by two 
disulfide bonds and an S-glucosidic linkage to a Cys residue helix-connecting loop7–10. As such, sublancin belongs 
to the family of glycocins, which share the sugar modification and require a similar machinery for biosynthe-
sis, post-translational modification and secretion11,12. The glucopeptide sublancin displays bactericidal activity 
against a range of other Gram-positive organisms, including various bacilli. In addition, it was recently shown 
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that sublancin also displays immunomodulatory activities13,14. The mechanism by which sublancin excerts its bac-
tericidal effect is not fully understood, but it has been shown to require key factors of the sugar phophotransferase 
system15. The genes encoding for the production of sublancin are not native to the 168 strain, but they have been 
introduced into the genome by the SPβ phage16–18. The precursor to sublancin is encoded by sunA, which is the 
first gene of an operon that includes four other genes named sunT, bdbA, sunS and bdbB7,17,18. SunT is responsible 
for proteolytic removal of the leader peptide from pre-sublancin and transport of mature sublancin to the extra-
cellular milieu7. Additionally, the thiol-disulfide oxidoreductase BdbB is involved in sublancin maturation by for-
mation of the two disulfide bonds7,19. SunS was shown to be responsible for addition of an S-linked UDP-glucose 
to Cys22 of sublancin8. BdbA is a thiol-disulfide oxidoreductase but, unlike BdbB, BdbA is dispensable for pro-
duction of active sublancin7. The final gene involved in the production of sublancin is sunI, which encodes the 
immunity protein that must be expressed to protect B. subtilis from the toxic effect of sublancin. Therefore, strains 
of B. subtilis are sensitive to sublancin if they do not produce SunI20. Notably, the sunI gene is not part of the sunA 
operon, but it is expressed from its own promoter and a rho-independent terminator is located between the two 
genes2 (Fig. 1A). Although the sunA, sunT, bdbA, sunS and bdbB genes are conserved in other glycocin-producing 
bacteria, the structures of the respective operons differ11.
Sublancin production is influenced by several regulatory factors as schematically represented in Fig. 1B. The two 
extracytoplasmic function (ECF) sigma factors σM and σX positively effect sublancin expression through the transcrip-
tion factor Abh21. A paralogue of Abh is the transcription factor AbrB that negatively regulates sunA expression22. A 
further negative regulator of sublancin is Rok23, which is known to bind to regions of foreign DNA that have higher 
levels of A + T than the native DNA24. As well as being regulated by these ‘standard’ transcriptional regulators, the 
sunA gene can also be regulated in a condition-dependent manner. For example, the two-component regulatory sys-
tem YvrGHb has been described as positively affecting the expression of the sun operon, although this may be through 
its regulation of sigX25. Furthermore, sunA is negatively regulated by Spx during disulfide stress26,27. The regulator 
responsible for carbon catabolite repression CcpA negatively regulates sunA in the presence of glucose28, and sunA 
also appears to be under the influence of the regulator of genetic competence and quorum sensing ComA29. Lastly, it 
has been reported that sunA is expressed heterogeneously30. This complex control of sunA transcription is only partly 
understood, and a challenge lies in dissecting the different factors responsible for this gene’s expression pattern21.
This study is aimed at identifying factors responsible for the heterogeneous expression of sunA. In addition, we 
assessed whether the heterogeneity in the expression of sunA is also reflected in the expression of the immunity 
gene sunI. For this purpose, we analyzed the expression of sunA-GFP or sunI-GFP promoter fusions in several 
mutant backgrounds. This allowed us to delineate the different factors regulating sunA. Here we show that while 
multiple regulators influence the levels of sunA expression, the heterogeneity of the sunA promoter (PsunA) 
activity is controlled by only three of them, namely Spo0A, AbrB and Rok. Conversely, through analysis of the 
sunI-GFP promoter fusion we found that the immunity gene sunI is homogeneously expressed in all cells of the 
investigated population, which will protect them from the toxic effects of sublancin.
Materials and Methods
Strains, plasmids and primers. The bacterial strains and plasmids used in this study are listed in Table 1. 
Primers used for creating sunI, rok or abh mutations are listed in Table 2. Escherichia coli strains were grown in 
Lysogeny Broth (LB) at 37 °C with vigorous shaking or on LB agar plates. For standard laboratory practices B. sub-
tilis was grown in either LB broth at 37 °C with vigorous shaking or on LB agar plates. B. subtilis was transformed 
using a standard transformation procedure with plasmid or chromosomal DNA (isolated as described by Bron 
& Venema, 1972)31 using Paris Medium consisting of 10.7 mg/ml K2HPO4, 6 mg/ml KH2PO4, 1 mg/ml trisodium 
citrate, 0.02 mg/ml MgSO4, 1% glucose, 0.1% casamino acids (Difco), 20 μg/ml L-tryptophan, 2.2 μg/ml ferric 
ammonium citrate and 20 mM potassium glutamate19. Growth media were supplemented with antibiotics where 
appropriate; ampicillin (Ap) 100 μg/ml, chloramphenicol (Cm) 5 μg/ml, erythromycin (Em) 1 μg/ml, kanamycin 
Figure 1. The sunA locus and its regulatory network. (A) Schematic representation of the sunA locus. Genes 
are indicated by large arrows, promoters by elbow arrows, and terminators by pins. (B) The regulatory network 
determining the expression of the sunA gene for sublancin as adapted from21. Arrows represent interactions that 
stimulate sunA expression and blunt-ended lines represent inhibitory interactions. The part of the network that 
determines sunA expression heterogeneity as determined in the present studies is indicated by grey shading.
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(Km) 20 μg/ml, phleomycin (Phleo) 4 μg/ml, spectinomycin (Sp) 100 μg/ml. 0.5 mM IPTG was added to induce 
expression of the sad67 allele. Deletion mutants created in this study were constructed as described by Tanaka et 
al., and introduced into the genome of strain 16832. Mutations were confirmed by PCR and functional screens for 
competence and enzyme secretion. Promoter-GFP fusions used in this study are single copy chromosomal inser-
tions. Integration of the promoter-GFP fusions into the genome was achieved via single crossover recombination 
using the pBaSysBioII plasmid33. This plasmid cannot replicate in B. subtilis, ensuring the presence of only a single 
copy of the promoter-GFP fusion in the chromosome, which precludes unwanted gene dosage effects. The PsunI-
GFP promoter fusion was constructed as described by Botella et al.33 using the PsunI primers presented in Table 2.
The possible loss of the PsunA-GFP fusion from B. subtilis 168 upon overnight culturing in the absence of 
selective antibiotic pressure was tested by plating 100 µl aliquots of 1000x and 10000x dilutions of the culture on 
LB-agar without antibiotics. Upon overnight incubation of the plates, the colonies were imaged for GFP fluores-
cence on an Amersham Typhoon imager, and the fluorescence intensities of all colonies on a plate were quantified 
using ImageJ.
Strains/genotype Relevant properties Reference
168 trpC2 parental strain used in this study; produces sublancin 168 Kunst et al.44
ΔSPβ SPβ prophage deletion mutant; sublancin sensitive Dorenbos et al.7
PsunA-GFP Carries a sunA promoter GFP fusion created with pBaSysBioII; Spr Piersma et al.36
PsunI-GFP Carries a sunI promoter GFP fusion created with pBaSysBioII; Spr This work
sad67 IPTG-inducible Spo0A-P production; Cmr Ireton et al.37
sad67 PsunA-GFP IPTG-inducible Spo0A-P production; Cmr, Spr This work
sad67 PsunI-GFP IPTG-inducible Spo0A-P production, Cmr, Spr This work
Δspo0A Kmr Boonstra et al.45
Δspo0A PsunA-GFP Kmr, Spr This work
ΔclpX Cmr Wiegert and Schumann 200146
ΔclpX PsunA-GFP Cmr, Spr This work
ΔabbA Kmr Blencke et al.47
ΔabbA PsunA-GFP Kmr, Spr This work
ΔyjbH BFA2867, Emr Kobayashi et al.48
ΔyjbH PsunA-GFP BFA2867, Emr, Spr This work
ΔsigX HB10103, Kmr Luo & Helmann, 200921
ΔsigX PsunA-GFP HB10103, Kmr, Spr This work
ΔsigM HB10016, Luo & Helmann, 200921
ΔsigM PsunA-GFP HB10016, Tcr, Spr This work
ΔsigXM Kmr, Tcr This work
ΔccpA GP302, Emr Ludwig et al.49
ΔccpA PsunA-GFP GP302, Emr, Spr This work
Δspx TR2, Cmr Rochat et al.27
Δspx PsunA-GFP TR2, Cmr, Spr This work
ΔabrB TMB082, Tcr Jordan et al.50
ΔabrB PsunA-GFP TMB082, Spr This work
ΔabrB PsunI-GFP TMB082, Spr This work
Δabh Phleor This work
Δabh PsunA-GFP Phleor, Spr This work
Δrok Phleor This work
Δrok PsunA-GFP Phleor, Spr This work
Δrok ΔabrB PsunA-GFP Phleor, Tcr, Spr This work
Δrok sad67 PsunA-GFP Phleor, Cmr, Spr This work
Δrok PsunI-GFP Phleor, Spr This work
ΔcomA Cmr Guillen et al.51
ΔcomA PsunA-GFP Cmr, Spr This work
ΔyvrGH Kmr Serizawa et al.25
ΔyvrGH PsunA-GFP Kmr, Spr This work
Plasmid name Relevant properties Reference
BaSysBioII LIC cloning vector for creating GFP promoter fusions. Botella et al.33
PsunA-GFP sunA promoter region cloned into BaSysBio II Piersma et al.36
PsunI-GFP sunI promoter region cloned into BaSysBio II This work
Table 1. B. subtilis strains and plasmids.
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Sublancin susceptibility. Sublancin susceptibility assays were carried out as previously described with 
minor modifications7,34. A 1:100 dilution of an overnight culture of B. subtilis 168∆SPβ was plated either on 
regular (full-strength) LB agar medium or, for comparison with microscopy-derived results, on four-fold diluted 
LB medium containing 1% NaCl and 1.5% agarose (quarter-strength LB medium) in a Petri dish. This created a 
lawn of sublancin-susceptible cells onto which 1 µl of an overnight culture of a sublancin-producing strain was 
spotted. After overnight incubation at 37 °C, the Petri dish was photographed and halo- and colony diameters in 
the images were quantified using ImageJ. Since sublancin is distributed over a surface, the diameters of colony and 
halo were used to calculate the halo surface area. Halo surface sizes of mutant producer strains were normalized 
against that of the wild-type strain to enable comparisons to promoter activity assays.
Microtiter plate experiments. Strains containing the PsunA-GFP fusion were grown overnight in LB. The 
next day the strains were diluted 1:200 in the same medium and grown for 2.5 hours.
= − − × .d (OD OD ) /(OD OD ) 1 cm977 900 sample 977 900 reference
OD600 values of each sample were divided by the path length.
To compare data from microscopy experiments with data from microtiter plate experiments, the LB was 
diluted to quarter strength and the NaCl corrected to the standard 1%.
Time-lapse microscopy. Agarose slides were prepared as described by Botella et al.33, using quarter-strength 
LB with 1.5% agarose (Merck). To prepare bacteria for time-lapse microscopy, strains were grown overnight in LB 
medium containing the appropriate antibiotics. After a 1:200 dilution in quarter-strength LB medium, the strains 
were grown for 2.5 h. Next, the strains were spotted onto a 1 to 1.5 mm wide strip of agarose on the prepared slide. 
A time-lapse movie of the growing bacteria was recorded using a Leica DM 5500 B microscope. Phase contrast 
and fluorescence images were recorded every 5 to 7 minutes, depending on the number of samples. Fluorescence 
pictures were recorded using a Leica EL6000 lamp with an L5 filter cube. Both the lamp intensity and the attenu-
ator inside the microscope were set to 10% to minimize phototoxicity.
Image analysis. Data was extracted from recorded images using FIJI, an ImageJ-based software package35 
(http://pacific.mpi-cbg.de/wiki/index.php/Fiji), which is freely available. Cellular fluorescence and GFP expres-
sion heterogeneity were measured with the TLM-Quant pipeline as described previously36. This method consists 
of two types of visualizations of the data: 1. Expression heterogeneity expressed as standard deviation in cellu-
lar fluorescence, to enable easy comparison of different samples. 2. A 3D histogram to determine if bistability 
exists within the samples that are found to display expression heterogeneity. All experiments were carried out in 
duplicate. Briefly, the following properties were extracted from the images that were obtained in the microscopy 
analysis. Cell outlines were derived from phase contrast images and used to distinguish cells in the fluorescent 
channel. From individual cells, fluorescence values were obtained, which were then corrected for background 
fluorescence. All cells combined were considered a population, from which a mean value and a standard deviation 
(SD) were calculated. The SD was used as a measure for heterogeneity, and was corrected for the SD of fluores-
cence caused by external factors. An inducible Pspac-GFP fusion strain was used as a control for homogeneous 
promoter activity that allowed a correction of the SD in fluorescence. To this end, the strain was induced with four 
different concentrations of isopropyl β-D-1-thiogalactopyranoside (IPTG) and the obtained SD values of all data 
points were combined in one figure, where the average fluorescence was plotted on the X-axis and the SD on the 
Y-axis. A trend-line was drawn through these points, showing that a linear correlation exists between fluorescence 
intensity and inherent heterogeneity. The equation of this line was subtracted from the calculated heterogeneity 
values, to correct for heterogeneity that is inherent to the microscopy setup and the detected GFP transcription. 
After correction, the coefficient of variation was calculated as the ratio between the SD in fluorescence intensity 
and the mean fluorescence. In this assay, a high heterogeneity value is an indicator that can reflect two different 
situations, namely: i. a higher SD in cellular fluorescence, which originates from a higher number of fluorescent 











Table 2. Primers used in this study to create sunI, rok, or abh mutations.
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Results and Discussion
Expression of sunA and production of active sublancin on LB are determined by the transcrip-
tional regulators Abh, AbrB, Rok, Spo0A, σM and σX. Active sublancin was previously shown to 
be produced at the end of the exponential growth phase and throughout stationary phase34. To calibrate our 
experimental set-up, we analyzed the promoter activity of sunA using a GFP promoter fusion and time-lapse 
microscopy with cells growing on LB agar. Notably, LB was selected for these analyses, because little if any active 
sublancin is produced when cells are grown on minimal media within the 17 h time frame of our experiments. 
This is in line with previous findings of van der Donk et al.8, who reported production of active sublancin on M9 
minimal medium starting 48 h after inoculation and reaching an optimum at 60–72 hours. Thus, the onset in the 
secretion of active sublancin on minimal medium is relatively late by Bacillus standards, and cannot be captured 
in our time-lapse microscopy setup.
When the cells were grown on LB, a low level of GFP expression was observed during the exponential phase 
of growth before the promoter became highly active during stationary phase (Fig. 2). As shown by the size of the 
error bars in the recorded fluorescence in Fig. 2B, there was a substantial heterogeneity in GFP fluorescence. This 
expression behavior is comparable to a previous expression analysis of the sunA promoter30 and we therefore con-
cluded that our set-up was suitable for a dissection of factors involved in the heterogeneous expression of sunA. 
Of note, we verified that the observed heterogeneity in GFP fluorescence was not due to loss of the integrated 
pBaSysBioII plasmid used to generate the sunA-GFP fusion by plating bacteria cultured overnight in the absence 
of selective antibiotic pressure and quantifying the fluorescence intensities of the resulting colonies. The fluores-
cence intensities in the histogram in Supplementary Fig. S1 show that all plated cells were fluorescent and, thus, 
had retained the integrated plasmid.
Several transcriptional regulators have been shown to influence the expression of sunA. From a 
literature-based search, we deduced that the regulators AbbA, Abh, AbrB, CcpA, ClpX, ComA, Rok, SigM, SigX, 
Spo0A, Spx, YjbH, YvrGH have been associated with changes in the expression level of sunA. Accordingly, we 
deleted the respective genes from the genome of the strain expressing the sunA-GFP promoter fusion (Table 1). 
Next, we carried out expression analyses by monitoring the levels of GFP produced in these strains during growth 
on LB. Under the tested conditions, no significant effects on the activity of PsunA-GFP were observed when the 
ccpA, comA, spx, or yvrGHb genes were deleted (data not shown). This relates, most likely, to differences in the 
growth conditions applied here and in previous studies that had implicated the respective regulators in sunA 
expression. On the other hand, clear effects on the activity of PsunA-GFP and the production of active sublancin 
were observed in strains with mutations in the abh, abrB, sigM, sigX, spo0A or rok genes (Fig. 3).
Previous investigation of the regulation of sunA expression showed that regulators of the entry into stationary 
phase play a role in the production of sublancin21. Indeed, deletion of spo0A resulted in a complete elimination of 
sunA transcription and sublancin production (Supplementary Fig. S2). Conversely, induction of the sad67 allele 
of spo0A, which leads to the Spo0A pathway being permanently activated37, resulted in very high GFP expression 
from the PsunA-GFP promoter fusion and strongly enhanced production of active sublancin (Fig. 3). One of the 
main transcriptional rearrangements caused by activation of the Spo0A pathway is the blocking of abrB tran-
scription. Deletion of abrB from the B. subtilis genome resulted in enhanced levels of transcription from the sunA 
promoter and, accordingly, enhanced production of active sublancin (Fig. 3). Abh is a paralogue of AbrB that 
functions by binding to many of the same transcription factor binding sites as AbrB. Notably, Abh was previously 
shown to activate transcription of sunA38 and, indeed, the deletion of abh caused a severe down-regulation of the 
transcription from the sunA promoter as well as sublancin production (Fig. 3). Expression of abh is regulated 
by two ECF sigma factors, σM and σX. While individual deletions of the sigM or sigX genes had less dramatic 
effects on PsunA activity and sublancin production than the abh deletion, combining the sigM and sigX deletions 
in one strain resulted in a severe reduction in the activity of PsunA and the production of sublancin to similar 
levels as observed for the abh mutant strain (Fig. 3). Intriguingly, significant sunA expression was observed in 
the sigM mutant strain, whereas only marginal production of active sublancin was detectable. This would sug-
gest that SigM impacts on expression of a gene needed for the production of active sublancin. Altogether, our 
present observations were in good agreement with the previous findings of Luo & Helmann21 as represented 
in Fig. 1. Notably, AbrB is also post-translationally controlled by AbbA39 and, accordingly, deletion of the abbA 
gene resulted in a reduction in transcription from the sunA promoter (Supplementary Fig. S3). Lastly, during 
exponential growth the transcriptional repressor Rok is under the control of AbrB40. Rok has been shown to bind 
to the promoter region of sunA23,24 and we therefore also assessed the influence of a rok deletion on PsunA-GFP 
activity and sublancin expression. Indeed, the rok deletion did increase the sunA promoter activity and sublancin 
expression. In fact, this deletion resulted in the highest levels of PsunA-GFP and sublancin activity observed in 
the present studies (Fig. 3). Furthermore, the effect of the rok deletion was dominant over the effects of induction 
of the sad67 allele of spo0A or the deletion of abrB (Fig. 3). Together, these findings show that Abh, AbrB, Rok, 
Spo0A, σM and σX are the key determinants for sunA expression and production of active sublancin in B. subtilis 
cells growing on LB.
AbrB, Rok and Spo0A determine sunA expression heterogeneity. While sunA has previously been 
shown to be expressed heterogeneously, the regulatory basis for this heterogeneous expression has not yet been 
established. To identify the origin of the observed sunA expression heterogeneity, we quantified this heterogene-
ity in abh, abrB, rok, spo0A-sad67, sigM or sigX mutant strains with the PsunA-GFP fusion using the previously 
developed TLM-Quant pipeline36. Specifically, the heterogeneity in sunA expression was measured at four differ-
ent time points across the growth curve, namely at mid-exponential growth, transition stage, and two late stages 
when large microcolonies had been established (Figs 2 and 4). As shown in Fig. 4, the sunA expression heteroge-
neity was neither influenced by individual deletion of the abh, sigX or sigM genes, nor the deletion of both sigX 
and sigM. On the other hand, the sunA expression heterogeneity was strongly reduced by deletion of abrB or rok 
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and the induced expression of the sad67 allele of spo0A. In the first place, these findings show that AbrB, Rok and 
Spo0A are the key determinants for sunA expression heterogeneity. A second important conclusion is that sunA 
expression heterogeneity is not strictly related to the level of PsunA promoter activity. In particular, while PsunA 
promoter activity in the abh or sigX and sigM mutants was very low, the sunA expression heterogeneity in these 
mutant strains was very similar to that observed in the parental strain 168. Conversely, while the PsunA promoter 
activity was at the highest level in strains lacking abrB and/or rok, these strains showed the lowest levels of sunA 
expression heterogeneity. Overall the results show that high-level expression of sunA is accompanied by relatively 
low expression heterogeneity, whereas lower-level sunA expression is accompanied by relatively high expression 
heterogeneity (Fig. 4).
The induced expression of the sad67 allele of Spo0A resulted in a ~3.5-fold increase in the sunA promoter 
activity and a ~2-fold increase in production of active sublancin while, at the same time it caused a ~2- to 6-fold 
reduction in sunA expression heterogeneity depending on the growth stage. Spo0A-Sad67 is a constitutively active 
mutant form of Spo0A that mimics the behavior of Spo0A-P37. Spo0A is well studied for its role in the bistable 
process of sporulation. In this complex regulatory cascade, the sporulation phosphorelay switching mechanism 
transfers a phosphate group to Spo0A to form the regulatory active Spo0A-P41,42. Expression of Spo0A is under 
the influence of several positive feedback loops and these auto-inducing loops cause the bistable phosphorylation 
of Spo0A. This mechanism ensures on-off switching of the sporulation phenomenon. Unfortunately, our exper-
imental setup does not allow conclusions on a possible bistable expression of the sunA-GFP fusion by distinct 
sub-populations of the cells in the presence or absence of Spo0A-Sad67 induction. Nevertheless, Spo0A remains 
required for sunA expression under these conditions as the deletion of spo0A completely blocked PsunA promoter 
activity (Supplementary Fig. S2).
AbrB and Rok are under the direct influence of Spo0A, and our experiments show that they are key factors 
not only controlling the sunA expression level and consequently production of active sublancin, but also the 
Figure 2. Expression of sunA as determined by time-lapse fluorescence microscopy. (A) Montage of time-
lapse fluorescence microscopy images of B. subtilis 168 containing a PsunA promoter-GFP fusion and grown 
on LB. The time points at which images were captured are shown. (B) Growth curve and fluorescence of B. 
subtilis 168 PsunA-GFP as derived from the complete analysis for which selected images are shown in panel 
A. The cumulative feret’s diameter represented by the black line was used as a measure for growth (black 
line). The mean fluorescence at each time point is represented by a grey line and the error bars represent the 
level of fluorescence heterogeneity. The arrows indicate sample points for quantification of the fluorescence 
heterogeneity as shown in Fig. 3. Fluorescence recordings in the grey zone were used to determine the 
maximum promoter activity as shown in Fig. 3.
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Figure 3. Correlation of sunA promoter activity with the production of active sublancin. (A) Comparison 
of the maximum sunA promoter activity (black bars) to the production of active sublancin (grey bars). The 
maximum sunA promoter activity values for each investigated mutant strain were determined by time-lapse 
fluorescence microscopy as in Fig. 2, and normalized against the maximum promoter activity determined 
for the parental strain 168 (WT). The production of active sublancin by each investigated mutant strain was 
determined by measuring the surface of sublancin-induced growth inhibition zones on a lawn of sublancin-
susceptible cells of the B. subtilis ΔSPβ strain as shown in panel B. The sublancin production by each strain 
was then normalized against that of the parental strain 168. (B) Representative images for growth inhibition as 
caused by sublancin-producing cells that were spotted on a lawn of B. subtilis ΔSPβ. Mutations in the genome of 
sublancin-producing cells are marked in each image. WT, B. subtilis 168.
Figure 4. Quantification of sunA expression heterogeneity. Heterogeneity in the expression of the sunA 
promoter-GFP fusion in growing cells of various mutant strains and the parental strain 168 (WT) was assessed 
by time-lapse fluorescence microscopy. GFP expression heterogeneity was assessed at different time points 
along the growth curve as marked by arrows in Fig. 2. Correspondingly, the differently grey-shaded bars 
indicated for each strain represent, from left to right, sunA expression heterogeneity in the exponential growth 
phase, the transition phase, the early stationary phase and the late stationary phase. Heterogeneity values were 
calculated as the mean variance in cellular GFP fluorescence (indicated in arbitrary units, AU).
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heterogeneity of expression of PsunA-GFP. The heterogeneity in the abrB and rok mutants was reduced ~6-fold 
compared to the wild-type strain and combining these two mutations reduced this even further to barely detect-
able levels for most growth stages (Fig. 4). Interestingly, although deletion of rok or abrB resulted in similar levels 
of heterogeneity, the rok deletion caused a rise in PsunA promoter activity that was 2-fold higher than in the abrB 
mutant. The production of active sublancin in the rok deletion mutant was ~1.6 times higher than in the abrB 
deletion strain (Figs 3 and 4). The Abh protein is known to compete with AbrB for binding to the promoter region 
of sunA to induce its expression22. Consistent with this AbrB-antagonizing effect of Abh, the deletion of abh from 
the genome resulted in a ~3-fold reduction in sunA expression and a failure to produce active sublancin, whereas 
the level of heterogeneity in sunA expression was not altered. Similarly, the levels of promoter activity and sub-
lancin production were reduced in the sigma factor mutants but, in this case, the sunA expression heterogeneity 
was maintained. A sigX sigM double mutant behaved very similarly to an abh mutant in all respects, which is 
consistent with the requirement of σX and σM for abh expression (Figs 1,3 and 4).
Taken together, the present results suggest that the interplay between Spo0A-P, AbrB and Rok is crucial for 
generating heterogeneity in sunA expression when cells are grown on LB. We note that the inhibitory effects of 
the sunA repressors AbrB and Rok are not equal in all cells and that the majority of sunA expression heterogeneity 
is removed upon deletion of their genes. The deletion of rok had the strongest effect on the sunA promoter, but 
since AbrB is also known to repress the expression of rok, increased levels of Rok are probably present in the abrB 
mutant cells, which is likely to account for the differences in the levels of active sublancin produced by the abrB 
and rok mutant strains. It seems therefore that the generation of sunA expression heterogeneity is due to a balance 
Figure 5. Expression of sunI in growing cells as determined by time-lapse fluorescence microscopy. (A) 
Montage of time-lapse fluorescence microscopy images of B. subtilis 168 containing a PsunI promoter-GFP 
fusion and grown on LB. The time points at which images were captured are shown. (B) Growth curve and 
fluorescence of B. subtilis 168 PsunI-GFP as derived from the complete analysis for which selected images 
are shown in panel A. The cumulative feret’s diameter represented by the black line was used as a measure for 
growth (black line). The mean fluorescence at each time point is represented by a grey line and the error bars 
represent the level of fluorescence heterogeneity. The arrows indicate sample points for quantification of the 
fluorescence heterogeneity as shown in Fig. 6. Fluorescence recordings in the grey zone were used to determine 
the maximum promoter activity as shown in Fig. 6.
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in the level of phosphorylation of Spo0A, which upon phosphorylation acts to repress the expression of abrB 
and rok. This potential balance between the regulation of the transcription factors generating sunA expression 
heterogeneity is highlighted by the dramatically reduced heterogeneity in sunA expression in the abrB rok double 
mutant. Lastly, we should point out that, by creating the sunA promoter GFP fusion through single cross-over 
integration of the pBaSysBioII plasmid into the sunA locus, the sunA regulatory sequences were duplicated. This 
could potentially influence the effective level of sunA regulators due to a dilution effect. On the other hand, 
the presently followed approach precludes potentially deleterious polar effects on the expression of downstream 
genes in the sunA operon (i.e. sunT, bdbA, sunS and bdbB), which would have prevented the combined analysis 
of sunA expression at the single-cell level and assessment of the overall levels of sublancin production in one and 
the same system. Further, in the context of our single cell GFP expression analyses, it is important to bear in mind 
that upon sunA repression, there may be the same level of heterogeneity in the bacterial population, but a lower 
mean GFP level. This relates to the possibility that, if fewer cells at any given moment have the sunA promoter 
switched on, these cells still need to dilute the already synthesized GFP molecules, which could lead to heteroge-
neity in the population’s GFP levels. Instead, when sunA repression is relieved, most cells will turn the sunA pro-
moter on and, accordingly, the mean fluorescence will go up while heterogeneity in the GFP level may decrease.
sunI expression is homogenous throughout the cell population. The sunI gene encodes the immu-
nity protein for sublancin, and all cells producing active sublancin must express this gene to be immune to the 
effects of this bacteriocin. However, it was not known to date whether sunI expression would be heterogeneous, 
following the heterogeneous expression of sunA, or whether sunI expression would be homogeneous throughout 
the population. We therefore assessed the expression of sunI in cells growing on LB and expressing a PsunI pro-
moter GFP fusion. As evidenced by time-lapse fluorescence microscopy (Fig. 5), sunI expression remained highly 
Figure 6. Comparison of the promoter activity and expression heterogeneity of sunA and sunI in growing cells. 
(A) Comparison of the maximum sunI promoter activity in various mutant strains to the maximum promoter 
activity of sunA in cells of the parental strain B. subtilis 168 (WT). The maximum sunI promoter activity 
values for each investigated mutant strain were determined by time-lapse fluorescence microscopy as in Fig. 5, 
and normalized against the maximum promoter activity determined for the parental strain 168 (WT). (B) 
Comparison of the expression heterogeneity of various strains expressing a sunI promoter-GFP fusion to the 
expression heterogeneity determined for the sunA promoter-GFP fusion in the parental strain 168 (WT). GFP 
expression heterogeneity was assessed at different time points along the growth curve as marked by arrows in 
Fig. 5. Correspondingly, the differently grey-shaded bars indicated for each strain represent, from left to right, 
sunA or sunI expression heterogeneity in the exponential growth phase, the transition phase, the early stationary 
phase and the late stationary phase. Heterogeneity values were calculated as the mean variance in cellular GFP 
fluorescence (indicated in arbitrary units, AU).
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homogeneous over all stages of the growth curve. Notably, the activity of the sunI promoter was only slightly 
lower than that of the sunA promoter and it was only mildly influenced by deletions of abrB or rok (Fig. 6A). 
Induced expression of the sad67 allele of spo0A had no significant effect on sunI promoter activity. Importantly, 
none of the mutations that had major effects on the heterogeneous expression of sunA had a significant effect on 
the very low level of heterogeneity in the expression of sunI. In fact the expression heterogeneity of sunI in the 
parental strain 168 was within the same range as that determined for sunA in mutants lacking the abrB or rok 
genes. It can thus be concluded that sunI is very homogeneously expressed in cells growing on LB.
Altogether, the present findings show that the expression of sunA and sunI is very differently regulated. This 
is consistent with the studies by Nicolas et al.2, where the overall expression level of sunA was shown to be highly 
variable depending on the growth condition studied. In contrast, the variability in expression level of sunI was 
relatively small across the 104 conditions tested, which seems to suggest that sunI is less susceptible to transcrip-
tional regulation than sunA. The strong involvement of Rok in sunA regulation is noteworthy in this context, since 
Rok is a negative regulator of genes involved in horizontal gene transfer. Rok inhibits uptake of foreign DNA by 
inhibiting the main transcription factor of competence, ComK40, and it also represses the transcription of genes 
in A + T rich regions of the B. subtilis chromosome, which are the result of horizontal gene transfer24. The SPβ 
prophage, and therefore sunA and sunI, are A + T rich and have been acquired by B. subtilis through horizontal 
gene transfer. Thus, one would expect not only sunA, but also sunI to be a target for Rok regulation. However, the 
marginal influence of Rok on sunI expression as observed in the present study suggests that the regulation of this 
gene by Rok was minimized to ensure optimal sublancin immunity of the cells that contain the SPβ prophage.
Conclusions
Here we describe the differential regulation of genes encoding for the bacteriocin sublancin and its cognate 
immunity protein. Only part of the B. subtilis population expresses sunA at maximum level. However, the whole 
population can benefit from this high-level expression by creating an environment in which B. subtilis is able to 
kill competitors, leaving more nutrients for itself. On the other hand, for the whole isogenic population to survive, 
the immunity protein must be expressed continuously by all cells. This apparently placed a strong selective pres-
sure on the promoter of sunI to remain consistently stable within the population, but it may have allowed the sunA 
promoter to evolve to become growth phase-dependently and heterogeneously expressed. Heterogeneous pro-
duction of sublancin could be beneficial for the population since only a small number of producers are required 
to provide bactericidal activity. Other members of the bacterial colony would then have more resources available 
for other processes. Here it is noteworthy that the sunA gene is amongst the most highly expressed genes of B. 
subtilis. Thus, producing sublancin is likely to be ‘expensive’ to the cell, especially since at least four additional 
proteins (i.e. SunT, SunS, BdbB and SunI) are needed to secrete active sublancin and since protein synthesis is a 
resource-costly process43. In this context, the timing of sunA gene expression seems optimal as the production 
of sublancin is likely most beneficial during late exponential phase and stationary phase when nutrients become 
limited. Its production would not only give the producing cells a competitive advantage over other species in the 
vicinity, but also release additional nutrients due to the death of such competitors. Lastly, constitutive sunI expres-
sion will not only provide a competitive advantage to cells in the sublancin-producing population, but also to the 
SPβ prophage, which ensures in this way that it is stably maintained in the B. subtilis genome. Clearly, cells that 
would lose the SPβ prophage would become susceptible to sublancin and therefore die. Altogether, this suggests 
a mutualistic evolutionary strategy entertained by the SPβ prophage and its Bacillus host, ensuring both stable 
prophage maintenance and a maximal competitive advantage for the host at minimal costs.
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